Back to Search
Start Over
Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer's Disease and Parkinson's Disease.
- Source :
-
Aging and disease [Aging Dis] 2023 Jun 01; Vol. 14 (3), pp. 652-669. Date of Electronic Publication: 2023 Jun 01. - Publication Year :
- 2023
-
Abstract
- A key pathological feature of neurodegenerative diseases (NDs) such as Alzheimer's disease (AD) and Parkinson's disease (PD) is the accumulation of aggregated and misfolded protein aggregates with limited effective therapeutic agents. TFEB (transcription factor EB), a key regulator of lysosomal biogenesis and autophagy, plays a pivotal role in the degradation of protein aggregates and has thus been regarded as a promising therapeutic target for these NDs. Here, we systematically summarize the molecular mechanisms and function of TFEB regulation. We then discuss the roles of TFEB and autophagy-lysosome pathways in major neurodegenerative diseases including AD and PD. Finally, we illustrate small molecule TFEB activators with protective roles in NDs animal models, which show great potential for being further developed into novel anti-neurodegenerative agents. Overall, targeting TFEB for enhancing lysosomal biogenesis and autophagy may represent a promising opportunity for the discovery of disease-modifying therapeutics for neurodegenerative disorders though more in-depth basic and clinical studies are required in the future.
Details
- Language :
- English
- ISSN :
- 2152-5250
- Volume :
- 14
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Aging and disease
- Publication Type :
- Academic Journal
- Accession number :
- 37191408
- Full Text :
- https://doi.org/10.14336/AD.2022.0927